These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25424470)

  • 1. Cholesterol levels in fragile X syndrome.
    Berry-Kravis E; Levin R; Shah H; Mathur S; Darnell JC; Ouyang B
    Am J Med Genet A; 2015 Feb; 167A(2):379-84. PubMed ID: 25424470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights of altered lipid profile in Fragile X Syndrome.
    Çaku A; Seidah NG; Lortie A; Gagné N; Perron P; Dubé J; Corbin F
    PLoS One; 2017; 12(3):e0174301. PubMed ID: 28334053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incomplete silencing of full mutation alleles in males with fragile X syndrome is associated with autistic features.
    Baker EK; Arpone M; Aliaga SM; Bretherton L; Kraan CM; Bui M; Slater HR; Ling L; Francis D; Hunter MF; Elliott J; Rogers C; Field M; Cohen J; Cornish K; Santa Maria L; Faundes V; Curotto B; Morales P; Trigo C; Salas I; Alliende AM; Amor DJ; Godler DE
    Mol Autism; 2019; 10():21. PubMed ID: 31073396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low Levels of HDL in Fragile X Syndrome Patients.
    Lisik MZ; Gutmajster E; Sieroń AL
    Lipids; 2016 Feb; 51(2):189-92. PubMed ID: 26712713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
    Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA
    Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autism Symptoms in Fragile X Syndrome.
    Niu M; Han Y; Dy ABC; Du J; Jin H; Qin J; Zhang J; Li Q; Hagerman RJ
    J Child Neurol; 2017 Sep; 32(10):903-909. PubMed ID: 28617074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced serum levels of pro-inflammatory chemokines in fragile X syndrome.
    Van Dijck A; Barbosa S; Bermudez-Martin P; Khalfallah O; Gilet C; Martinuzzi E; Elinck E; Kooy RF; Glaichenhaus N; Davidovic L
    BMC Neurol; 2020 Apr; 20(1):138. PubMed ID: 32295518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ICAM5 as a Novel Target for Treating Cognitive Impairment in Fragile X Syndrome.
    Pei YP; Wang YY; Liu D; Lei HY; Yang ZH; Zhang ZW; Han M; Cheng K; Chen YS; Li JQ; Cheng GR; Xu L; Wu QM; McClintock SM; Yang Y; Zhang Y; Zeng Y
    J Neurosci; 2020 Feb; 40(6):1355-1365. PubMed ID: 31882402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of lipid rafts cholesterol with clinical profile in fragile X syndrome.
    Toupin A; Benachenhou S; Abolghasemi A; Laroui A; Galarneau L; Fülöp T; Corbin F; Çaku A
    Sci Rep; 2022 Feb; 12(1):2936. PubMed ID: 35190617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragile X syndrome: a review of clinical and molecular diagnoses.
    Ciaccio C; Fontana L; Milani D; Tabano S; Miozzo M; Esposito S
    Ital J Pediatr; 2017 Apr; 43(1):39. PubMed ID: 28420439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism-based treatments in neurodevelopmental disorders: fragile X syndrome.
    Berry-Kravis E
    Pediatr Neurol; 2014 Apr; 50(4):297-302. PubMed ID: 24518745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral abnormalities in the Fmr1-KO2 mouse model of fragile X syndrome: The relevance of early life phases.
    Gaudissard J; Ginger M; Premoli M; Memo M; Frick A; Pietropaolo S
    Autism Res; 2017 Oct; 10(10):1584-1596. PubMed ID: 28590057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein synthesis levels are increased in a subset of individuals with fragile X syndrome.
    Jacquemont S; Pacini L; Jønch AE; Cencelli G; Rozenberg I; He Y; D'Andrea L; Pedini G; Eldeeb M; Willemsen R; Gasparini F; Tassone F; Hagerman R; Gomez-Mancilla B; Bagni C
    Hum Mol Genet; 2018 Jun; 27(12):2039-2051. PubMed ID: 29590342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective Deletion of Astroglial FMRP Dysregulates Glutamate Transporter GLT1 and Contributes to Fragile X Syndrome Phenotypes In Vivo.
    Higashimori H; Schin CS; Chiang MS; Morel L; Shoneye TA; Nelson DL; Yang Y
    J Neurosci; 2016 Jul; 36(27):7079-94. PubMed ID: 27383586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lovastatin on behavior in children and adults with fragile X syndrome: an open-label study.
    Çaku A; Pellerin D; Bouvier P; Riou E; Corbin F
    Am J Med Genet A; 2014 Nov; 164A(11):2834-42. PubMed ID: 25258112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin as a Novel Interventional Candidate for Fragile X Syndrome with Autism Spectrum Disorder in Humans.
    Won J; Jin Y; Choi J; Park S; Lee TH; Lee SR; Chang KT; Hong Y
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28632163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling fragile X syndrome in the Fmr1 knockout mouse.
    Kazdoba TM; Leach PT; Silverman JL; Crawley JN
    Intractable Rare Dis Res; 2014 Nov; 3(4):118-33. PubMed ID: 25606362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An effective strategy of using molecular testing to screen mentally retarded individuals for fragile X syndrome.
    Tzeng CC; Lin SJ; Chen YJ; Kuo PL; Jong YJ; Tsai LP; Chen RM
    Diagn Mol Pathol; 2001 Mar; 10(1):34-40. PubMed ID: 11277393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BDNF in fragile X syndrome.
    Castrén ML; Castrén E
    Neuropharmacology; 2014 Jan; 76 Pt C():729-36. PubMed ID: 23727436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emergence and stability of attention deficit hyperactivity disorder in boys with fragile X syndrome.
    Grefer M; Flory K; Cornish K; Hatton D; Roberts J
    J Intellect Disabil Res; 2016 Feb; 60(2):167-78. PubMed ID: 26610738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.